首页> 外文期刊>TMR Integrative Medicine >Analysis of 610 cases inpatients with chronic heart failure
【24h】

Analysis of 610 cases inpatients with chronic heart failure

机译:610例慢性心力衰竭住院患者分析

获取原文
           

摘要

Abstract Objective: To analyze the clinical characteristics and medical treatment of hospitalized patients with chronic heart failure, and provide medication for the patients. Methods: According to medical records of inpatients, demographic information, etiology, clinical features and treatment information were collected. Results: A total of 610 cases with heart failure from our hospital between July 2010 and June 2016 were analyzed. The average age of all the patients was 63. Males accounted for 50.49%.There were 82.7% patients with NYHA functional classification at III-IV. 31.3% patients with coronary artery disease, 28.4% with rheumatic heart diseases and 21.8% with expansion of heart disease. 27.4 percent of the patients with the left ventricular ejection fraction lower than 40%.There were 78.9% patients received aldosterone antagonist treatment, 63.4% received ACEI / ARB, 62.1% received digoxin, 59.8% received beta blockers, and 75.4% patients received decoction, 80.8% received Chinese patent medicine. Conclusion: The study have shown that high utilization of Traditional Chinese medicine is to highlight the advantages of the combination of Traditional Chinese and Western medicine in the treatment of heart failure. The usage of spironolactone, ACEI / ARB, beta blockers in our hospital was lower than the guideline ratio, higher than that of the national average. However, the use of diureticis is lower than that of national average, which may relate to the use of damp-clearing herbs. Clinicians should pay attention to the high utilization rate of digoxin. Patients with the left ventricular ejection fraction > 50% accounted for 61.1%, which required more attention should be paied to the diagnosis and treatment of patients with heart failure of the ejection fraction remains.
机译:摘要目的:分析住院慢性心力衰竭患者的临床特点及治疗方法,为患者提供药物治疗。方法:根据住院病人的病历资料,收集人口统计资料,病因,临床特点和治疗资料。结果:2010年7月至2016年6月间,我院共分析了610例心力衰竭患者。所有患者的平均年龄为63岁。男性占50.49%。III-IV级有NYHA功能分类的患者为82.7%。冠心病患者为31.3%,风湿性心脏病患者为28.4%,心脏病扩展为21.8%。 27.4%的左室射血分数低于40%的患者。接受醛固酮拮抗剂治疗的患者为78.9%,接受ACEI / ARB的患者为63.4%,接受地高辛的为62.1%,接受β受体阻滞剂的为59.8%,接受汤剂的为75.4% ,中成药80.8%。结论:研究表明,中药的高利用率突出了中西医结合治疗心力衰竭的优势。我院使用螺内酯,ACEI / ARB,β受体阻滞剂的使用率低于指南比率,高于全国平均水平。但是,利尿剂的使用低于全国平均水平,这可能与使用清湿药有关。临床医生应注意地高辛的高利用率。左心室射血分数> 50%的患者占61.1%,这需要更多的重视,心力衰竭患者的诊断和治疗仍然需要射血分数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号